Marinus Pharmaceuticals, Inc. provided Preliminary revenue guidance for the fourth quarter and full year ended December 31, 2022. For the quarter, the company expects net product revenue of between $2.2 and $2.3 million.
For the full year, the company expects net product revenue of between $2.8 and $2.9 million.